SARAH WHITEMAN: Open Payments
NPI 1134752587 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 24 payments from 10 companies in 2025. Trend: 2023 $738 · 2024 $434 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $111 |
| PFIZER INC. | 5 | $88 |
| Sumitomo Pharma America, Inc. | 4 | $74 |
| UROGEN PHARMA, INC. | 2 | $36 |
| Ferring Pharmaceuticals Inc. | 2 | $33 |
| Astellas Pharma US Inc | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Cumberland Pharmaceuticals, Inc. | 1 | $20 |
| Boston Scientific Corporation | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: ERLEADA, XTANDI, GEMTESA, ORGOVYX, ADSTILADRIN, Padcev, Nubeqa, CALDOLOR.
Industry payments across PA — which companies pay providers there.
